REDHILL BIOPHARMA LTD. Current Liabilities
REDHILL BIOPHARMA LTD. (RDHL) had Current Liabilities of $22.29 million as of 2025-06-30, per its 6-K filed 2025-09-05.
Financial Statements › Notes
ifrs-full:CurrentLiabilities · last filed 2025-09-05
- 2025-06-30: Current Liabilities $22.29M.
- 2024-12-31: Current Liabilities $22.22M.
- 2024-06-30: Current Liabilities $21.23M.
- 2023-12-31: Current Liabilities $19.98M; Current Liabilities as first filed $19.24M.
| Period end | Current Liabilities | Current Liabilities as first filed |
|---|---|---|
| 2025-06-30 | $22.29M 6-K · filed 2025-09-05 | |
| 2024-12-31 | $22.22M 6-K · filed 2025-09-05 | |
| 2024-06-30 | $21.23M 6-K · filed 2024-08-29 | |
| 2023-12-31 | $19.98M 20-F · filed 2025-04-10 | $19.24M 20-F · filed 2024-04-08 |
| 2023-06-30 | $28.19M 6-K · filed 2023-08-17 | |
| 2022-12-31 | $197.45M 20-F · filed 2024-04-08 | |
| 2022-06-30 | $166.41M 6-K · filed 2022-11-07 | |
| 2021-12-31 | $81.47M 20-F · filed 2023-04-28 | |
| 2021-06-30 | $79.17M 6-K · filed 2021-08-26 | |
| 2020-12-31 | $73.23M 20-F · filed 2022-03-17 | |
| 2020-06-30 | $35.87M 6-K · filed 2020-08-13 | |
| 2019-12-31 | $10.62M 20-F · filed 2021-03-18 | |
| 2019-06-30 | $14.05M 6-K · filed 2019-07-23 | |
| 2018-12-31 | $10.38M 20-F · filed 2020-03-04 | |
| 2018-06-30 | $9.88M 6-K · filed 2018-08-30 | |
| 2017-12-31 | $11.83M 20-F · filed 2019-02-26 | |
| 2016-12-31 | $5.36M 20-F · filed 2018-02-22 |